Search research articles
Contact Us
Filters
Showing results (231-240 of 348) with videos related to
Page
of 35
Sort By:
Nature
|
May 3, 2023
Targeting PD-L2-RGMb overcomes microbiome-related immunotherapy resistance
Joon Seok Park, Francesca S Gazzaniga, Meng Wu, et al.
Cell
|
June 26, 2018
LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
Wanqiang Sheng, Martin W LaFleur, Thao H Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 4, 2019
Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockade
Mohammad Rashidian, Martin W LaFleur, Vincent L Verschoor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2019
PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUN
Abdallah Flaifel, Wanling Xie, David A Braun, et al.
Nature
|
August 9, 2016
Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
Se Jin Im, Masao Hashimoto, Michael Y Gerner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2018
Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy
Carmela Passaro, Quazim Alayo, Isabella De Laura, et al.
Immunity
|
February 24, 2017
Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
Suzanne George, Diana Miao, George D Demetri, et al.
Cancer Immunology Research
|
June 7, 2014
Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade
Zachary A Cooper, Vikram R Juneja, Peter T Sage, et al.
Science Advances
|
December 8, 2022
Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo
James A Torchia, Alexander H Tavares, Laura S Carstensen, et al.
The Journal of General Virology
|
January 29, 2015
Nef promotes evasion of human immunodeficiency virus type 1-infected cells from the CTLA-4-mediated inhibition of T-cell activation
Mohamed El-Far, Petronela Ancuta, Jean-Pierre Routy, et al.
Page
of 35
Search research articles
Search
Showing results (231-240 of 348) with videos related to
Sort By:
Page
of 35
Nature
|
May 3, 2023
Targeting PD-L2-RGMb overcomes microbiome-related immunotherapy resistance
Joon Seok Park, Francesca S Gazzaniga, Meng Wu, et al.
Cell
|
June 26, 2018
LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
Wanqiang Sheng, Martin W LaFleur, Thao H Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 4, 2019
Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockade
Mohammad Rashidian, Martin W LaFleur, Vincent L Verschoor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2019
PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUN
Abdallah Flaifel, Wanling Xie, David A Braun, et al.
Nature
|
August 9, 2016
Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
Se Jin Im, Masao Hashimoto, Michael Y Gerner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2018
Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy
Carmela Passaro, Quazim Alayo, Isabella De Laura, et al.
Immunity
|
February 24, 2017
Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
Suzanne George, Diana Miao, George D Demetri, et al.
Cancer Immunology Research
|
June 7, 2014
Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade
Zachary A Cooper, Vikram R Juneja, Peter T Sage, et al.
Science Advances
|
December 8, 2022
Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo
James A Torchia, Alexander H Tavares, Laura S Carstensen, et al.
The Journal of General Virology
|
January 29, 2015
Nef promotes evasion of human immunodeficiency virus type 1-infected cells from the CTLA-4-mediated inhibition of T-cell activation
Mohamed El-Far, Petronela Ancuta, Jean-Pierre Routy, et al.
Page
of 35